Ori Spotlight Episode Seven – Dr. Annalisa Jenkins, Strategic Advisor, Ori Biotech

Episode Seven

On episode seven of the Ori Spotlight Podcast we sat down with Dr. Annalisa Jenkins, Strategic Advisor for Ori and advisor to the FDA, to discuss the changes she’s seen in CGT pricing and market access models over the years. As board member for many private and public companies, Annalisa recounts how it all started and how she sees the industry evolving. She’s passionate about the idea that we need to continue to embrace innovation to drive down prices while still having successful companies that can meet the needs of both their patients and shareholders.

Learn more about Dr. Annalisa Jenkins https://www.linkedin.com/in/annalisajenkins/

Related Articles

Ori Spotlight Podcast - Dennis Powers

Ori Spotlight Episode Six– Dennis Powers, Vice President of Business Development & Sales Engineering at G-CON Manufacturing

Read more
Ori Spotlight Podcast - Rahul Singhv

Ori Spotlight Episode Five – Rahul Singhvi , Co-Founder and CEO at Resilience

Read more
Ori Spotlight Podcast - Deanna M. Petersen

Ori Spotlight Episode Four – Deanna M. Petersen, Chief Business Officer at AVROBIO

Read more